The Dermatology Digest

DECEMBER 30, 2024

More than 200 residents, medical students and Fellow members have committed to volunteer for MBWS outreach events at universities, hospitals, and community venues, with a planned distribution of 10,000 gift bags with tips for managing winter skin and free moisturizing products generously provided by campaign sponsor, Clinique.

Webinar 78

Webinar Education Social Media Dermatology 78

MedEsthetics

AUGUST 11, 2023

atopic dermatitis, acne, inflammatory conditions, skincare, acne treatment, peptide, medical aesthetics, clinical trials, phase 1 study, British journal of dermatology

Dermatitis 60

Dermatitis Skincare Clinic Medical 60

The Dermatology Digest

SEPTEMBER 14, 2023

Daniel Butler discusses strategies for diagnosing atypical dermatitis and overcoming medication access issues, including the use of alternative metrics to measure disease severity, practicing physician patience, and learning to navigate the payer system. We are so reliant on our physical exam skills [and] appropriately so. “And

Dermatitis 48

Dermatitis Treatments Medical Office 48

US Dermatologt Partners

OCTOBER 7, 2024

Dermatitis is an umbrella term that refers to a group of skin conditions that cause skin irritation, sensitivity, redness, and similar symptoms. As the name implies, eyelid dermatitis or eyelid eczema, is a form of dermatitis that impacts the upper or lower eyelid. What is Eyelid Dermatitis?

Eczema 41

Eczema Dermatitis Irritation Management 41

Lipgloss and Aftershave

SEPTEMBER 3, 2024

Third Annual Integrative Esthetics Conference for The Future of Skincare The third annual Integrative Esthetics Conference is a pioneering event by LearnSkin , that uniquely bridges medical professionals and estheticians, It will take place on September 29, 2024, in Arlington, Texas, and offers 7 educational topics.

Education 52

Education Esthetician Medical Esthetics 52

The Dermatology Digest

MAY 23, 2024

TDD Editorial Advisory Board Member Raj Chovatiya, MD, PhD, the Founder and Director of the Center for Medical Dermatology and Immunology Research in Chicago, updates viewers on the true role of Malassezia yeast in the pathophysiology of seborrheic dermatitis and explains how this new understanding is changing the way the condition is treated.

Dermatitis 74

Dermatitis Dermatology Medical 74

The Dermatology Digest

DECEMBER 5, 2024

Dr. Schön is a distinguished Professor and Director of the Department of Dermatology, Venereology, and Allergology at the University Medical Center Göttingen in Germany. In many areas of chronic inflammatory skin diseases, but also in other organ systems with immunologically mediated diseases, there is a significant unmet medical need.

Innovations 36

Innovations Dermatitis Dermatology Medical 36

The Dermatology Digest

JANUARY 22, 2024

s ZORYVE topical foam, 0.3%, is now officially available for the treatment of seborrheic dermatitis. Food and Drug Administration (FDA) approved ZORYVE foam for the treatment of seborrheic dermatitis in individuals 9 years of age and older on December 15, 2023. Arcutis Biotherapeutics, Inc.’s

Dermatitis 78

Dermatitis Treatments Innovations Clinic 78

The Dermatology Digest

APRIL 9, 2024

Patient images are missing in studies of atopic dermatitis (AD), new research shows. “Images are also important for understanding that atopic dermatitis looks very different in different types of skin. This means that as little as 0.3 per thousand of the AD patients were represented in images in the published articles.

Eczema 74

Eczema Dermatitis Education Hospital 74

The Dermatology Digest

AUGUST 21, 2024

Childhood obesity can contribute to the development of common immune-mediated skin diseases (IMSDs), such as alopecia areata, atopic dermatitis, and psoriasis, new research finds. Maintaining a healthy weight could potentially help lower the chances of developing these skin conditions, the researchers suggest.

Dermatitis 69

Dermatitis Diet Dermatology Medical 69

The Dermatology Digest

APRIL 7, 2024

A newly developed therapeutic ladder can help guide dermatologists and patients on the use of nonsteroidal treatment options for atopic dermatitis (AD). Ch’en, a medical student at the Albert Einstein College of Medicine in the Bronx, New York, and Peter A. The study appears in Dermatitis.

Treatments 77

Treatments Dermatitis Therapy Medical 77

The Dermatology Digest

DECEMBER 11, 2024

IMAGE CAPTION: In a mouse model of contact dermatitis, preventive application of a cream containing SYM2081 (right image) reduced skin swelling compared to placebo (left image). This finding led us to wonder if doing the opposite would have a beneficial effect, says Dr. Kaplan.

Therapy 41

Therapy Rosacea Entrepreneurship Eczema 41

The Dermatology Digest

JANUARY 4, 2024

Smoking is known to increase the risk of developing atopic dermatitis (AD), even in adolescents. Furthermore, adolescents who use e-cigarettes are at increased risk of developing the “atopic march” consisting of the triad of asthma, atopic dermatitis, and allergic and allergic rhinitis compared to non-smokers,” the study authors write.

Dermatitis 69

Dermatitis Dermatology Medical Education 69

Dermatology Times

NOVEMBER 20, 2023

Jared Gollob, MD, Chief Medical Officer of Kymera Therapeutics, spoke with Dermatology Times to discuss these trial results.

Office 74

Office Dermatitis Medical Dermatology 74

Dermatology Times

DECEMBER 10, 2024

Panelists discuss how managing atopic dermatitis presents complex clinical challenges, including treatment resistance, medication adherence, identifying triggers, and tailoring therapies to individual patient needs and disease severity.

Dermatitis 36

Dermatitis Clinic Therapy Management 36

The Dermatology Digest

JANUARY 14, 2024

People with seborrheic dermatitis who don’t use topical steroids are 3.5 Zoryve foam is a once-daily steroid-free topical for use in all skin and hair types that effectively clears and controls seborrheic dermatitis. Food and Drug Administration (FDA) approved topical roflumilast foam (Zoryve, Arcutis) for seborrheic dermatitis.

Dermatitis 72

Dermatitis Office Dermatology Safety 72

The Dermatology Digest

DECEMBER 13, 2024

Food and Drug Administration (FDA) has approved nemolizumab (Nemluvio, Galderma) for the treatment of patients aged 12 and older with moderate to severe atopic dermatitis, in combination with topical corticosteroids (TCS) and/or calcineurin inhibitors (TCI) when the disease is not adequately controlled with topical prescription therapies.

Dermatitis 69

Dermatitis Safety Eczema Dermatology 69

The Dermatology Digest

APRIL 22, 2025

MSCI, Clinical Associate Professor, Rosalind Franklin University of Medicine and Science Chicago Medical School and Founder and Director of the Center for Medical Dermatology + Immunology Research in Chicago, IL, in a news release. A systemic therapy, alitretinoin, is approved in Canada, the European Union, South Korea, and Israel.

Eczema 36

Eczema Dermatology Therapy Office 36

The Dermatology Digest

FEBRUARY 9, 2024

Early skin microbiome and metabolome signatures can predict atopic dermatitis in infants aged 6 to 18 months old, according to new research being presented at the 2024 American Academy of Allergy, Asthma & Immunology Annual Meeting. The rates of atopic dermatitis were 30.8% in 6-month-old children and 20.8% at 18 months of age.

Dermatitis 74

Dermatitis Moisturization Training Dermatology 74

The Dermatology Digest

FEBRUARY 26, 2024

Shared-decision making focused on weighing risks versus benefits is key when choosing the most appropriate systemic atopic dermatitis (AD) treatment for a patient, according to new research presented at the 2024 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting in Washington, DC. some of the biologics).

Treatments 74

Treatments Dermatitis Pharmaceutical Clinic 74

US Dermatologt Partners

AUGUST 23, 2023

Atopic Dermatitis, more commonly known as eczema, is a common skin condition impacting one in 10 Americans. Dermatology Partners affiliate office Medical Dermatology Specialists in Phoenix, Arizona , “Like other chronic skin conditions, eczema is best managed with the help of a dermatologist. Millions of people in the U.S.

Eczema 36

Eczema Dermatitis Management Skin Health 36

The Dermatology Digest

JANUARY 29, 2024

Food and Drug Administration (FDA) for treatment of seborrheic dermatitis in adult and pediatric patients 9 years of age and older in December 2023. It is the first drug approved for seborrheic dermatitis with a new mechanism of action in over two decades. in seborrheic dermatitis. in seborrheic dermatitis.

Dermatitis 74

Dermatitis Safety Dermatology Treatments 74

The Dermatology Digest

MARCH 21, 2024

March is National Sleep Awareness Month, and nighttime itching is known to keep families affected by atopic dermatitis (AD) up at night. Food and Drug Administration for VTAMA (tapinarof) cream, 1% for the topical treatment of atopic dermatitis (AD) in adults and children 2 years of age and older.

Dermatitis 68

Dermatitis Dermatology Medical Treatments 68

Dermatology Times

DECEMBER 4, 2024

Gina Mangin, MPAS, PA-C, discusses how developing an effective atopic dermatitis treatment plan requires a personalized, multifaceted approach that combines proper skin care, trigger avoidance, topical medications, and potentially systemic therapies based on the severity of symptoms and individual patient needs.

Dermatitis 36

Dermatitis Treatments Therapy Medical 36

Dermatology Times

AUGUST 11, 2023

Diego Ruiz Dasilva, MD, FAAD, shares treatment approaches to atopic dermatitis, focusing on medications such as dupilumab and upadacitinib.

Dermatitis 36

Dermatitis Management Medical Treatments 36

The Dermatology Digest

FEBRUARY 14, 2024

Food and Drug Administration (FDA) has accepted Galderma’s Biologics License Applications for nemolizumab for the treatment of patients with prurigo nodularis (PN) and for adolescents and adults with moderate to severe atopic dermatitis (AD). Galderma is planning for multiple regulatory submissions in 2024.

Dermatitis 78

Dermatitis Clinic Safety Dermatology 78

West Lake Dermatology

MARCH 25, 2024

Seborrheic Dermatitis (SD) is common skin condition known for its chronic and recurrent nature. Understanding seborrheic dermatitis is the first step towards managing it effectively. What Is Seborrheic Dermatitis? Who’s At Risk For Developing Seborrheic Dermatitis? SD can affect individuals of all ages and races.

Dermatitis 36

Dermatitis Treatments Eczema Management 36

Dermatology Times

JUNE 10, 2024

Kristine Kucera, PA-C, MPAS, DHS, discusses prescribing a PDE-4 inhibitor for Mickey Bryson's psoriasis and atopic dermatitis, emphasizing the absence of FDA-approved medications like JAK inhibitors, while Bryson underscores the challenges of daily injections, likening it to insulin use.

Dermatitis 36

Dermatitis Management Injections Medical 36

Dermatology Times

DECEMBER 24, 2024

A panelist discusses how the current treatment options for atopic dermatitis range from topical corticosteroids and calcineurin inhibitors for mild cases to systemic medications such as dupilumab and Janus kinase inhibitors for moderate-to-severe disease, with selection based on factors such as disease severity, patient age, and safety considerations. (..)

Dermatitis 36

Dermatitis Safety Medical Treatments 36

Aesthetics Advisor

FEBRUARY 23, 2025

Alexs eczema, also known as atopic dermatitis, began in infancy with small, itchy patches on his wrists and handsa condition Kate, a seasoned nurse, was familiar with. Her decision to stop his medication was supported by medical professionals but is still controversial in some circles. Desai in a statement to The Epoch Times.

Eczema 36

Eczema Dermatitis Medical Clinic 36

The Dermatology Digest

APRIL 1, 2025

We have seen immense therapeutic innovation in the treatment of AD, PN, and chronic CSU, over the past decade, the reviews first author Raj Chovatiya, MD, PhD, MSCI,Founder and Director of the Center for Medical Dermatology + Immunology Research in Chicago,tells The Dermatology Digest.

Dermatitis 36

Dermatitis Dermatology Therapy Tools 36

The Dermatology Digest

FEBRUARY 10, 2025

FDA’s Fast Track designation is granted to investigational therapies that treat serious conditions and have the potential to address an unmet medical need. “Rezpegaldesleukin has the potential to address a significant unmet need for the millions of patients living with moderate-to-severe atopic dermatitis.

Dermatitis 36

Dermatitis Therapy Office Safety 36

First Derm

JUNE 23, 2024

1] Three main categories of eczema are atopic eczema, contact dermatitis and stasis dermatitis. Despite the potential side effects, appropriate use of topical steroids under medical advice is beneficial for controlling eczema. [4] The American Contact Dermatitis Society recognizes it as an allergen.

Eczema 59

Eczema Ingredients Dermatitis Irritation 59

The Dermatology Digest

JUNE 5, 2024

In the cross-sectional study, researchers analyzed data from more than 215,000 people aged 30 to 70 from the UK Biobank, which includef urine samples and electronic medical records.

Eczema 74

Eczema Diet Dermatitis Dermatology 74

Dermatology Times

AUGUST 20, 2024

A key opinion leader in the field of dermatology examines treatment strategies and medication sequencing for atopic and hand dermatitis in a 20-year-old female patient, focusing on clinical considerations and optimal management approaches.

Dermatitis 36

Dermatitis Management Clinic Medical 36

Dermatology Times

JULY 2, 2024

A medical expert in dermatology examines comprehensive treatment approaches for atopic dermatitis in a 12-year-old African American female patient, focusing on the assessment of topical and non-steroidal therapeutic options.

Dermatitis 36

Dermatitis Treatments Medical Dermatology 36

The Dermatology Digest

FEBRUARY 26, 2024

Impairment in tight junction expression has been shown to contribute to the barrier dysfunction observed in patients with atopic dermatitis. 3 Emollient enhancement, neonatal moisturizer, and barrier lipid replacement have all been discussed as epithelial barrier-protecting agents that may treat and possibly even prevent atopic dermatitis.

Dermatitis 74

Dermatitis Irritation Therapy Moisturization 74